MEDICINOVA, INC. (MNOV) Return on equity 2021–2025
MEDICINOVA, INC. (MNOV) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
28.9%FY2025 · since FY2021: -12.1% → 28.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 28.9% | — |
| FY2023 | 13.7% | — |
| FY2021 | -12.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice